Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroshi Morishita is active.

Publication


Featured researches published by Hiroshi Morishita.


The Journal of Pathology | 2003

Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung

Sho Goya; Hiroto Matsuoka; Masahide Mori; Hiroshi Morishita; Hiroshi Kida; Yoichiro Kobashi; Terufumi Kato; Yoshio Taguchi; Tadashi Osaki; Isao Tachibana; Kazuyuki Yoshizaki; Ichiro Kawase; Seiji Hayashi

A variety of pathological changes are seen in lymphoproliferative disorders of the lung but the histogenesis of these abnormalities is not yet fully understood. We previously showed that adenovirus vector‐mediated transient expression of both the human interleukin‐6 (IL‐6) and IL‐6 receptor (IL‐6R) genes, but not the IL‐6 gene alone, in the rat lung induced lymphocytic alveolitis. In the present study, we explored the lung pathology of human IL‐6 and IL‐6R double transgenic mice to elucidate the effects of prolonged IL‐6 signalling on the lung. The transgenic animals developed mononuclear cell accumulation in peribronchovascular regions, but little infiltration into alveolar spaces. Immunohistochemical analysis revealed that the cellular accumulations contained not only mixtures of inflammatory cells but also lymphoid tissue‐like structures. As the expression of CXCL13/BLC, the indispensable chemokine for lymphoid organogenesis, was recognized in the B cell follicles of the pulmonary lesions, we speculate that this chemokine plays an inductive role in the development of the lymphoid tissue‐like structures. These structures were distinguished from bronchus‐associated lymphoid tissues (BALTs) by their location and by the lack of lymphoepithelium, which is a characteristic of BALT. These findings imply that IL‐6 signalling may play a role in the pathogenesis of lymphoproliferative disorders of the lung. Copyright


Inflammation | 2004

Increased Level of Soluble E-Selectin in the Serum from Patients with Idiopathic Pulmonary Fibrosis

Seiji Hayashi; Kin′ya Abe; Hiroto Matsuoka; Sho Goya; Hiroshi Morishita; Masahide Mori; Toru Arai; Hiroshi Kida; Kazumi Nishino; Yoshito Takeda; Tadashi Osaki; Isao Tachibana; Kentaro Kimura; Soichiro Yokota; Yoshikazu Inoue; Mitsunori Sakatani

To elucidate the biological significance of selectin for idiopathic pulmonary fibrosis, we titrated the serum soluble E-selectin. From 31 cases of idiopathic pulmonary fibrosis patients without signs or symptoms of infection, the serum was obtained and the concentration was titrated by enzyme-linked immunosorbent assay. The serum soluble E-selectin titer was significantly higher than that of healthy controls. However, significant elevation was not observed in the sera from the patients with other pulmonary diseases, such as pulmonary emphysema, sarcoidosis, or bronchiectasis. In the patients with idiopathic pulmonary fibrosis, the number of white blood cells, C-reactive protein or lactate dehydrogenase activity did not show a significant relationship with the soluble E-selectin titer. About 16 out of the 31 idiopathic fibrosis patients, the serum surfactant apoprotein-A titer, which is a parameter of the disease activity of idiopathic pulmonary fibrosis, was also tested. The surfactant apoprotein-A titer was loosely correlated with the soluble E-selectin titer. These observations suggest that E-selectin may be relevant to the pathogenesis of idiopathic pulmonary fibrosis, and it may be a novel clinical parameter for idiopathic pulmonary fibrosis.


Cancer Genetics and Cytogenetics | 1995

Intermediate lymphocytic lymphoma with both t(14;19)(q32.3;q13.1) and t(3;22)(q27;q11.2)

Masashi Nakagawa; Haruo Sugiyama; Hiroyasu Ogawa; Shirou Tone; Hiroshi Morishita; Hiroshi Ikeda; Katsuyuki Aozasa; Masafumi Taniwaki; Tatsuo Abe; Tadamitsu Kishimoto

Chromosome translocations involving various chromosomes sites, including the sites of immunoglobulin loci (14q32,2p12,22q11) represent recurrent aberration in non-Hodgkin lymphoma (NHL). We report a novel case of intermediate lymphocytic lymphoma (ILL) with both t(14;19)(q32.3;q13.1) and t(3;22)(q27;q11.2). The t(14;19)(q32.3;q13.1) and t(3;22) (q27;q11.2) may represent reciprocal recombinations between immunoglobulin (Ig) H chain gene (14q32.3) and bcl-3(19q13.1) and between Ig lambda chain gene (22q11.2) and bcl-6 (3q27), respectively.


Internal Medicine | 2018

Spontaneous Regression of Allergic Bronchopulmonary Mycosis Due to Curvularia lunata

Shingo Nasu; Shingo Satoh; Kazunori Shimizu; Osamu Matsuno; Hiroshi Morishita; Takashi Yaguchi; Kunimitsu Kawahara; Hiroto Matsuoka

Allergic bronchopulmonary mycosis (ABPM) is a pulmonary hypersensitivity disease mainly caused by Aspergillus fumigatus. The mainstay treatment for ABPM is systemic corticosteroid therapy. A 25-year-old man presented with pulmonary infiltrates. His peripheral eosinophil, total serum IgE, and serum Aspergillus-specific IgE levels were elevated. The patient tested positive in a skin test for Aspergillus. However, sputum cultures revealed a Curvularia lunata infection. We therefore diagnosed ABPM possibly caused by C. lunata, which is rare in Japan. The clinical state of the patient improved under observation. Identification of the causative fungus is an important aspect of the ABPM diagnosis.


Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 1992

Case Report of Early Gastric Carcinoma after Surgery for Metastatic Ovarian Tumors.

Masahiro Ochiai; Hiroki Imazu; Takahiko Funabiki; Yoshihisa Marugami; Hisashi Yamaguchi; Katsuhiko Kamei; Hiroshi Fukui; Shigeru Hasegawa; Kazuhumi Arai; Masami Taniguchi; Takashi Uraguchi; Hiroshi Morishita; Masashi Suganuma; Atsushi Shikata; Yoshinori Sasayama; Toshihide Nobuta; Tomio Sawada

胃癌の卵巣転移は臨床上しばしぼ経験するが, 早期胃癌の卵巣転移報告例はいまだ少なく, 本邦では現在まで6例を数えるのみである. 今回われわれは卵巣転移を契機に発見された早期胃癌の1例を経験したので報告する.症例は33歳の女性で, 検診にて卵巣腫瘍を発見され, 両側卵巣摘除を行いKruckenberg腫瘍と診断した. 術後の検査で胃角上部後壁のIIc型早期胃癌を認め, 幽門側胃亜全摘, R2の手術を施行した. 病理所見は印環細胞癌, sm, ly2, v0, n2 (+) であった. 2度にわたる開腹所見にてP0, H0であり, 後腹膜リンパ節の腫大は触知しなかった. 術後1年の現在, 再発の徴候を認めていない.胃癌の卵巣への転移経路については古くから検討されてきたが, 対象のほとんどが進行癌で複数の転移巣を有することが多いため解析が困難なことが少なくなかった. 早期癌で1この点で有利であると考え, 集計報告6例を合わせ転移経路についての考察を加えた.


Immunity | 2005

Nonredundant Roles of Sema4A in the Immune System: Defective T Cell Priming and Th1/Th2 Regulation in Sema4A-Deficient Mice

Atsushi Kumanogoh; Takashi Shikina; Kazuhiro Suzuki; Satoshi Uematsu; Kazunori Yukawa; Shin-ichiro Kashiwamura; Hiroko Tsutsui; Midori Yamamoto; Hyota Takamatsu; Elizabeth P. Ko-Mitamura; Noriko Takegahara; Satoko Marukawa; Isao Ishida; Hiroshi Morishita; Durbaka V. R. Prasad; Manabu Tamura; Masayuki Mizui; Toshihiko Toyofuku; Shizuo Akira; Kiyoshi Takeda; Masaru Okabe; Hitoshi Kikutani


American Journal of Physiology-lung Cellular and Molecular Physiology | 2002

A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis

Hiroto Matsuoka; Toru Arai; Masahide Mori; Sho Goya; Hiroshi Kida; Hiroshi Morishita; Hiroshi Fujiwara; Isao Tachibana; Tadashi Osaki; Seiji Hayashi


American Journal of Respiratory Cell and Molecular Biology | 2004

Hepatoma-Derived Growth Factor Is Involved in Lung Remodeling by Stimulating Epithelial Growth

Masahide Mori; Hiroshi Morishita; Hideji Nakamura; Hiroto Matsuoka; Kenya Yoshida; Yoshihiko Kishima; Zhiwei Zhou; Hiroshi Kida; Toshiki Funakoshi; Sho Goya; Mitsuhiro Yoshida; Toru Kumagai; Isao Tachibana; Yoichi Yamamoto; Ichiro Kawase; Seiji Hayashi


Internal Medicine | 2001

Improvement of Anti-Hu-associated Paraneoplastic Sensory Neuropathy after Chemoradiotherapy in a Small Cell Lung Cancer Patient

Mayumi Suzuki; Hiromi Kimura; Isao Tachibana; Harutoshi Fujimura; Yuji Nakatsuji; Fuminobu Sugai; Ichiro Naba; Masayuki Nakamori; Hiroshi Morishita; Toru Arai; Tadashi Osaki; Seiji Hayashi


American Journal of Respiratory Cell and Molecular Biology | 2001

Microsatellite Instability in Transforming Growth Factor- β 1 Type II Receptor Gene in Alveolar Lining Epithelial Cells of Idiopathic Pulmonary Fibrosis

Masahide Mori; Hiroshi Kida; Hiroshi Morishita; Sho Goya; Hiroto Matsuoka; Toru Arai; Tadashi Osaki; Isao Tachibana; Satoru Yamamoto; Mitsunori Sakatani; Masami Ito; Takeshi Ogura; Seiji Hayashi

Collaboration


Dive into the Hiroshi Morishita's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge